Gastrointestinal Cancer News

The CDC today announced it has issued $22,800,000 in grant awards to increase colorectal cancer screening rates among people aged 50 to 76 years.

Twice as many patients with gastrointestinal cancers who took daily aspirin post-diagnosis  survived compared with nonusers, according to findings from a large study conducted in The Netherlands and presented at the European Society of Medical Oncology’s European Cancer Congress.

The FDA granted orphan drug designation to Blueprint Medicines drug candidate BLU-554 for the treatment of hepatocellular carcinoma, according to a press release.

In a cohort of Chinese patients, researchers found that routine blood and urine test results may be useful for predicting the probabilities of the risk for hepatocellular carcinoma, according to a poster presentation at the European Society for Medical Oncology’s European Cancer Congress.

Researchers from McMaster University in Canada discovered that overall, alcohol consumption significantly increases the risk of injury and alcohol-related cancers, and heavy alcohol consumption increases the risk for death. However, the combined risk of negative outcomes increased in low-income countries, but decreased in high-income countries.  

Tumors in younger colorectal cancer patients may have molecular differences related to epigenetics compared to the tumors of older colorectal cancer patients, according to research presented at European Society of Medical Oncology’s European Cancer Congress.

Tumors in younger colorectal cancer patients may have molecular differences related to epigenetics compared to the tumors of older colorectal cancer patients, according to research presented at European Society of Medical Oncology’s European Cancer Congress.

Treatment with the peptide receptor radionuclide therapy 177-Lu-Dotatate conferred clinically meaningful and statistically significant PFS improvements among patients with advanced gastrointestinal neuroendocrine tumors, according to the results of a phase 3 study presented at European Society for Medical Oncology’s European Cancer Congress.

Isolated hepatic perfusion was an effective treatment for patients with uveal melanoma who developed unresectable metastases confined to the liver, according to a poster presentation at the European Society for Medical Oncology’s European Cancer Congress.

Routine ultrasonographic surveillance led to improved survival and reduced mortality risk in patients with viral hepatitis and hepatocellular carcinoma, according to published findings.